Skip to content

The clinical study of nourishing yin and soothing liver capsule on poor ovarian response

The clinical study of nourishing yin and soothing liver capsule on poor ovarian response

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15005987
Enrollment
Unknown
Registered
2015-02-13
Start date
2012-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

poor ovarian response

Interventions

treatment group:nourishing yin and soothing liver capsule
control group:placebo of nourishing yin and soothing liver capsule

Sponsors

Guangdong Provincal Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
28 Years to 43 Years

Inclusion criteria

Inclusion criteria: 1. Diagnostic criterion: According to the definitions of Poor ovarian response from "The textbook of Human assisted reproductive technology"; 2. Syndrome diagnostic criterion: According to the definitions of Liver stagnation and Yin deficiency syndrome from "The national standard terminology of traditional Chinese medicine"; 3. Inclusive criterion: Prediction the possibility of poor ovarian response (meet one of the following criterion, and the third is necessary) (1) Aged 28-43 years; (2) Basal follicle-stimulating hormone >=10IU/L; (3) The Antral follicle count <=5; (4) The anti-Mullerian hormone is less than 1.6-3.5nmol/L.

Exclusion criteria

Exclusion criteria: 1. Polycystic ovarian syndrome (2003 Rotterdam diagnostic criteria); 2. Pelvic endometriosis(stage III-IV); serious Adenomyosis; 3. chromosome abnormalities; 4. Severe autoimmune disease and metabolic diseases; 5. The thickness of endometrial peri-ovulation period is less than 7mm; 6. Endocrinology disease (including Hyperprolactinemia); 7. The history of ovary operation or ovary resection (1 side or 2 sides); 8. Body mass index (BMI)>26.

Design outcomes

Primary

MeasureTime frame
follicle-stimulating hormone;luteinizing hormone;estrogen;anti-Mulerian hormone;inhibin-B;antral follicle count;

Countries

Chine

Contacts

Public ContactXiaoyun Wang
jiaoshouw@163.com+86 18922108066

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026